Four families fight to fund SPG50 gene therapy treatment for their kids

Four desperate American families to save their children from destroyed Genetic. There is treatment – but it is up to them to raise $ 1.15 million to finance a clinical trial.

Each of these families has a child with paralysis 50 (SPG50), a A rare nervous disorder This affects less than 100 people in the world.

In an interview with a camera with Fox News Digital, families talked about their race against time to secure treatment. (See the video at the top of the article.)

The feverish mother to save the clinical experience that can treat her daughter: “Treatment sits in the refrigerator”

The goal of families is to raise $ 1.15 million by the end of October to start trial in the United States, which established a non -profit organization called Jack Corner To help collect donations.

What is Spg50?

SPG50 slows down The child’s developmentIt gradually leads to poor perception, muscle weakness, poor speech and paralysis in the end, according to the National Organization for Rare Disorders.

(From left to right) Naomi Lukard, Mila Wood, Cadi Jobzaz, and Lincoln Mediros were diagnosed with SPG50 genetic disease. (Lindsey Jane Photography; Erika Mills; Leh Serena Photography; Candice Jean Photography)

Dr. Yves Elizabeth Beni, a epidemic scientist at the Ministry of Foreign Affairs, told the Ministry of Health and the medical contributor to the Ministry of Foreign Affairs at the Ministry of Health and Medical Contractors at the Ministry of Foreign Affairs at the Ministry of Foreign Affairs and the Medical Contractors at the Ministry of Foreign Affairs at the Ministry of Foreign Affairs at the Ministry of Foreign Ministry at the Ministry of Health and Medical Contribution to the Ministry of Foreign Affairs at the Ministry of Health and Medical Contractors at the Ministry of Foreign Affairs at the Ministry of Foreign Affairs, Dr. Yves Elizabeth Beni, a epidemic scientist in the Ministry of Foreign Affairs for Health Services The medical contributor to the Ministry of Foreign Affairs and the medical contributor to the Ministry of Foreign Affairs at the Ministry of Foreign Affairs at the Ministry of Foreign Affairs, Dr. Yves Elizabeth Beni, the epidemic scientist at the Ministry of Foreign Affairs at the Ministry of Foreign Affairs and the medical contributor to the Ministry of Foreign Affairs at the Ministry of Foreign Affairs and the medical contributor to the Ministry of Foreign Affairs at the Ministry of Foreign Affairs at the Ministry of Foreign Affairs at the Ministry of Foreign Affairs, and the medical contributor to the Ministry of Foreign Affairs and the medical contributor to the Wachins Group.

Children with Spg50 may face early Development delayThe weakness of the muscles and cramping, “continued over time, the symptoms could get worse, making it difficult for individuals affected by walking and performing daily activities.”

There is no currently approved treatment by the US Food and Drug Administration (FDA) for SPG50. However, one, thanks to Terry Peruvrolacis, is the father in Canada whose son was diagnosed in 2017.

The father created a drug to save his son from a rare disease, and now other families have become desperate to get it

“We told us to go home and love him – and they said that he would get from the waist to the bottom at the age of ten, and a dog bock of twenty.” “They said that he would never walk or speak, and he would need support for the rest of his life.”

He refused to accept this result, Pirovolakis began a mission to save his son – he liquidated his savings, met many experts and paid scholars to create a Genetic therapy.

Emma and Dylan Jobs, from Juno, Arkansas, has a 4 -year -old son, Kadi (in the photo), which was also diagnosed with SPG50 in 2023. (Leah Serena Photography)

In March 2022, his son received genetic treatment and is now prosperous. Then Pirovolakis opened the second stage study in the United States, which dealt with three other children. Everyone reported that the disease has stopped progressing and that their awareness had improved.

Now, the goal of moving to the third stage experience is that would allow more children-but because the drug has not yet depended on the FDA, families will need to raise funds for trial themselves.

Four families, one rare disease

Rebecca Lukard, from Litton, Colorado, desperate to treat her, 4 -year -old, who was diagnosed with SPG50 in 2023.

Her younger child, Jack, was diagnosed with SPG50 and received treatment in A. Previous trial Because of his younger year.

Lockard, from Littleton, Colorado, for their treatment, is fighting 4 -year -old Naomi, who was diagnosed with SPG50 in 2023. (Lindsey Jane Photographhy)

“Naomi is still unable to walk and have a wheelchair, while Jack moves quickly with the help of pedestrians,” Lukard told Fox News Digital. “Naomi has some of the voices and gestures that you use to communicate, while Jack sails his gestures and understanding what we say.”

“Every day, we are so strong that Jack received A meaningful treatment At an early age. Every day, we feel despair because we were unable to give Naomi the same quality of life. “

The mother with ALS is a rare arrang

Emma and Dylan Jobs, from Juno, Arkansas, has a 4 -year -old son, Kadi, was also diagnosed in 2023.

“Cade is still able to walk on short distances with a gait, but without treatment, we know that he will lose this ability,” Emma Jobs told Fox News Digital.

“There are eight doses, sitting and waiting for the children who need them strongly.”

“At the present time, we live with the daily fear of watching our son losing the skills and independence that he worked hard to gain. Without treatmentCADE’s future is one of the decline – in the end the loss of the ability to walk, feed himself, and do things that make him who is. ”

Jordan and Cody Mediros, from Scio, Oregon, were combined to know that their 4 -year -old Lincoln’s son has a SPG50.

Emma and Dylan Jobs, from Juno, Arkansas, has a 4 -year -old son, Kadi, who was diagnosed with SPG50 in 2023. (Candice Jean Photography)

“Since the diagnosis of Lincoln two years ago, SPG50 has slowly removed his ability to walk safely,” Jordan Midirus told Fox News Digital. “It often falls – several times a day. He cannot express his pain or frustrate.”

“The worst part is that there are eight doses, sitting and waiting for the children who need them strongly.”

Click here to get the Fox News app

In Susquehanna, Pennsylvania, Jami and Cody Wood welcomed the twin in 2022. In August 2025, they were destroyed to learn that one of the twins, Mila, had SPG50.

Just three weeks later, Mila took her first steps, a milestone that her parents described as “sweet and passed.”

“Without the medicine, we will judge it slowly, get up.”

“We know that there is one treatment available to it, and without that, you will likely lose this teacher as it took it to gain,” Jamie Wood told Fox News Digital.

“Genetic therapy is currently the option of the other treatment for Mila, and this experience is the only opportunity for our daughter to stop the progress of this Terrible. Without the medicine, we will be convicted that we should watch it slowly escape. “

We look forward

Hope is that after a successful experience in the third stage, the drug will obtain the approval of the Food and Drug Administration, which means that insurance companies and the government will cover this “huge burden of cost”, as he told the Fox News Digital.

Click here to register in our health newsletter

More importantly, it will be on NewbornSo we will have an opportunity to arrest and eliminate this disease. “

He said that Pirovolakis and his team are actively working with the FDA to ensure approval of this treatment, but “the process is only a simple thing.”

Jamie and Kodi Wood welcomed the twins in 2022. In August 2025, they were destroyed to know that one of the twins, Mila, had SPG50. (Erika Mills)

The challenge is that the Food and Drug Administration (FDA Hundreds of thousands of children.

“As for the large-scale conditions, savings of size helps reduce costs-but in our case, these requirements become almost impossible,” said Perovokis. “We need flexibility from this food and drug administration for very fiery conditions.”

For more health articles, visit www.foxnews.com/health

Anyone interested in learn more about SPG50 and families’ efforts can visit Jack Corner A website.

Fox News Digital continues the Food and Drug Administration to comment.